Insider Transactions in Q2 2023 at Jaguar Health, Inc. (JAGX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2023
|
Pravin R Chaturvedi Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
870
+43.37%
|
-
|
|
May 17
2023
|
James J Bochnowski |
BUY
Exercise of conversion of derivative security
|
Direct |
1,280
+36.13%
|
-
|
|
May 17
2023
|
John Micek |
BUY
Exercise of conversion of derivative security
|
Direct |
1,145
+46.72%
|
-
|
|
May 17
2023
|
Jonathan B. Siegel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,145
+46.72%
|
-
|
|
May 17
2023
|
Lisa A Conte |
BUY
Exercise of conversion of derivative security
|
Direct |
2,694
+40.25%
|
-
|
|
May 17
2023
|
Steven R. King |
BUY
Exercise of conversion of derivative security
|
Direct |
611
+38.77%
|
-
|
|
May 17
2023
|
Carol R. Lizak Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
431
+39.61%
|
-
|
|
May 17
2023
|
Jonathan S. Wolin |
BUY
Exercise of conversion of derivative security
|
Direct |
871
+45.29%
|
-
|
|
Apr 05
2023
|
Lisa A Conte |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+31.48%
|
-
|
|
Apr 05
2023
|
Steven R. King |
BUY
Exercise of conversion of derivative security
|
Direct |
177
+33.33%
|
-
|
|
Apr 05
2023
|
Jonathan S. Wolin |
BUY
Exercise of conversion of derivative security
|
Direct |
88
+32.71%
|
-
|
|
Apr 05
2023
|
Carol R. Lizak Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60
+20.98%
|
-
|
|
Apr 05
2023
|
Pravin R Chaturvedi Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44
+33.33%
|
-
|